OR WAIT null SECS
April 02, 2020
N4 Pharma will be undertaking a proof-of-concept research project using a COVID-19 DNA plasmid to demonstrate the ability of its delivery system, Nuvec, to collaborative partners developing DNA or RNA vaccines.
Considering the potential interaction of a drug with the delivery device early on in in development is integral to achieving the best combination.
The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.
March 02, 2020
Metrology has the potential to not only prevent harm to patients but also to support innovative therapeutic options.
February 21, 2020
Researchers at the Technical University of Munich (TUM) have discovered a way of continuously and precisely dosing active agents using an oil-hydrogel mixture.
February 12, 2020
Jim Walter will take on the role of vice-president of operations for Catalent’s Oral and Specialty Delivery business.
January 27, 2020
The facility will produce parenteral products and delivery devices and is set to create 460 new jobs.
January 03, 2020
Through the acquisition, Johnson & Johnson will gain access to Taris’ lead clinical-stage product, TAR-200.
January 02, 2020
PTE looks ahead to 2020’s edition of Pharmapack-the pharma industry’s dedicated packaging and drug delivery event.
Without careful consideration and understanding, new regulations for medical devices could lead to the withdrawal of combination products from the market.